Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 72 results.
User Information
Export Records
  1. 1.   A Novel Biological Activity of the STAT3 Inhibitor Stattic in Inhibiting Glutathione Reductase and Suppressing the Tumorigenicity of Human Cervical Cancer Cells via a ROS-Dependent Pathway
  2. Xia, Yuchen; Wang, Guihua; Jiang, Manli; Liu, Xueting; Zhao, Yan; Song, Yinghui; Jiang, Binyuan; Zhu, Demao; Hu, Ling; Zhang, Zhao; Cao, Ting; Wang,Jiming; Hu, Jinyue
  3. OncoTargets and therapy. 2021, Jul 5; 14: 4047-4060.
  1. 2.   Biochemical and biological studies of mouse APOBEC3
  2. Nair, S.; Sanchez-Martinez, S.; Ji, X.; Rein, A.
  3. Journal of Virology. 2014, Apr; 88(7): 3850-60.
  1. 3.   Modulation of Liver L-gamma-Glutamyl-L-cysteinylglycine Homeostasis By N-Acetyl-Glucosamine-thiazolidine-4(R)-carboxylic Acid in Mice
  2. Liu, J.; Cai, W. D.; Liu, W. S.; Han, B. Q.; Chang, J.; Yang, Y.
  3. American Journal of the Medical Sciences. 2012, Apr; 343(4): 310-315.
  1. 4.   Growth-inhibitory and chemosensitizing effects of the glutathione-S-transferase-p-activated nitric oxide donor PABA/NO in malignant gliomas
  2. Kogias, E.; Osterberg, N.; Baumer, B.; Psarras, N.; Koentges, C.; Papazoglou, A.; Saavedra, J. E.; Keefer, L. K.; Weyerbrock, A.
  3. International Journal of Cancer. 2012, Mar; 130(5): 1184-1194.
  1. 5.   Application of a water-soluble pyridyl disulfide amine linker for use in Cu-free click bioconjugation
  2. Thomas, J. D.; Burke, T. R.
  3. Tetrahedron Letters. 2011, Aug; 52(33): 4316-4319.
  1. 6.   Arsenic-Specific Stem Cell Selection During Malignant Transformation
  2. Tokar, E. J.; Qu, W.; Liu, J.; Liu, W.; Webber, M. M.; Phang, J. M.; Waalkes, M. P.
  3. Journal of the National Cancer Institute. 2010, May; 102(9): 638-649.
  1. 7.   Stabilization of the Nitric Oxide (NO) Prodrugs and Anticancer Leads, PABA/NO and Double JS-K, through Incorporation into PEG-Protected Nanoparticles
  2. Kumar, V.; Hong, S. Y.; Maciag, A. E.; Saavedra, J. E.; Adamson, D. H.; Prud'homme, R. K.; Keefer, L. K.; Chakrapani, H.
  3. Molecular Pharmaceutics. 2010, Jan-Feb; 7(1): 291-298.
  1. 8.   Nitric oxide prodrug JS-K inhibits ubiquitin E1 and kills tumor cells retaining wild-type p53
  2. Kitagaki, J.; Yang, Y.; Saavedra, J. E.; Colburn, N. H.; Keefer, L. K.; Perantoni, A. O.
  3. Oncogene. 2009 28(4): 619-624.
  1. 9.   Gene expression profiling for nitric oxide prodrug JS-K to kill HL-60 myeloid leukemia cells
  2. Liu, J.; Malavya, S.; Wang, X. Q.; Saavedra, J. E.; Keefer, L. K.; Tokar, E.; Qu, W.; Waalkes, M. P.; Shami, P. J.
  3. Genomics. 2009 94(1): 32-38.
  1. 10.   Modulation of Carcinogen Metabolism by Nitric Oxide-Aspirin 2 Is Associated with Suppression of DNA Damage and DNA Adduct Formation
  2. MacDonald, C. J.; Cheng, R.; Roberts, D. D.; Wink, D. A.; Yeh, G. C.
  3. Journal of Biological Chemistry. 2009 284(33): 22099-22107.
  1. 11.   The Nitric Oxide Prodrug JS-K and Its Structural Analogues as Cancer Therapeutic Agents
  2. Maciag, A. E.; Saavedra, J. E.; Chakrapani, H.
  3. Anti-cancer agents in medicinal chemistry. 2009 9(7): 798-803.
  1. 12.   Synthesis and evaluation of piperazine and homopiperazine analogues of JS-K, an anti-cancer lead compound
  2. Nandurdikar, R. S.; Maciag, A. E.; Citro, M. L.; Shami, P. J.; Keefer, L. K.; Saavedra, J. E.; Chakrapani, H.
  3. Bioorganic & Medicinal Chemistry Letters. 2009 19(10): 2760-2762.
  1. 13.   Structure Mechanism Insights and the Role of Nitric Oxide Donation Guide the Development of Oxadiazole-2-Oxides as Therapeutic Agents against Schistosomiasis
  2. Rai, G.; Sayed, A. A.; Lea, W. A.; Luecke, H. F.; Chakrapani, H.; Prast-Nielsen, S.; Jadhav, A.; Leister, W.; Shen, M.; Inglese, J.; Austin, C. P.; Keefer, L.; Arner, E.; Simeonov, A.; Maloney, D. J.; Williams, D. L.; Thomas, C. J.
  3. Journal of Medicinal Chemistry. 2009 52(20): 6474-6483.
  1. 14.   Synthesis, mechanistic studies, and anti-proliferative activity of glutathione/glutathione S-transferase-activated nitric oxide prodrugs
  2. Chakrapani, H.; Kalathur, R. C.; Maciag, A. E.; Citro, M. L.; Ji, X. H.; Keefer, L. K.; Saavedra, J. E.
  3. Bioorganic & Medicinal Chemistry. 2008 16(22): 9764-9771.
  1. 15.   GSTM1 and GSTT1 gene deletions and the risk for nasopharyngeal carcinoma in Han Chinese
  2. Guo, X. C.; O'Brien, S. J.; Zeng, Y.; Nelson, G. W.; Winkler, C. A.
  3. Cancer Epidemiology Biomarkers & Prevention. 2008 17(7): 1760-1763.
  1. 16.   Selective restoration of the selenoprotein population in a mouse hepatocyte selenoproteinless background with different mutant selenocysteine tRNAs lacking Um34
  2. Carlson, B. A.; Moustafa, M. E.; Sengupta, A.; Schweizer, U.; Shrimali, R.; Rao, M.; Zhong, N.; Wang, S.; Feigenbaum, L.; Lee, B. J.; Gladyshev, V. N.; Hatfield, D. L.
  3. Journal of Biological Chemistry. 2007, Nov; 282(45): 32591-32602.
  1. 17.   Nitric oxide prodrugs: Diazeniumdiolate anions of hindered secondary Amines
  2. Chakrapani, H.; Showalter, B. M.; Citro, M. L.; Keefer, L. K.; Saavedra, J. E.
  3. Organic Letters. 2007, Oct; 9(22): 4551-4554.
  1. 18.   Decreased selenoprotein expression alters the immune response during influenza virus infection in mice
  2. Sheridan, P. A.; Zhong, N. X.; Carlson, B. A.; Perella, C. M.; Hatfield, D. L.; Beck, M. A.
  3. Journal of Nutrition. 2007, Jun; 137(6): 1466-1471.
  1. 19.   Identification of a unique epigenetic sub-microenvironment in prostate cancer
  2. Rodriguez-Canales, J.; Hanson, J. C.; Tangrea, M. A.; Erickson, H. S.; Albert, P. S.; Wallis, B. S.; Richardson, A. M.; Pinto, P. A.; Linehan, W. M.; Gillespie, J. W.; Merin, M. J.; Libutti, S. K.; Woodson, K. G.; Emmert-Buck, M. R.; Chuaqui, R. F.
  3. Journal of Pathology. 2007, Mar; 211(4): 410-419.
  1. 20.   Effects of selenium supplementation on expression of glutathione peroxidase isoforms in cultured human lung adenocarcinoma cell lines
  2. Romanowska, M.; Kikawa, K. D.; Fields, J. R.; Maciag, A.; North, S. L.; Shiao, Y. H.; Kasprzak, K. S.; Anderson, L. M.
  3. Lung Cancer. 2007, Jan; 55(1): 35-42.
  1. 21.   Environmental genotoxicants/carcinogens and childhood cancer: Bridgeable gaps in scientific knowledge
  2. Anderson, L. M.
  3. Mutation Research-Genetic Toxicology and Environmental Mutagenesis. 2006, Sep; 608(2): 136-156.
  1. 22.   Antitumor activity of JS-K O-2-(2,4-dinitrophenyl) 1- (4-ethoxycarbonyl)piperazin-1-yl diazen-1-ium-1,2-diolate and related O-2-Aryl diazeniumdiolates in vitro and in vivo
  2. Shami, P. J.; Saavedra, J. E.; Bonifant, C. L.; Chu, J. X.; Udupi, V.; Malaviya, S.; Carr, B. I.; Kar, S.; Wang, M. F.; Jia, L.; Ji, X. H.; Keefer, L. K.
  3. Journal of Medicinal Chemistry. 2006, Jul; 49(14): 4356-4366.
  1. 23.   Variation in genes relevant to aromatic hydrocarbon metabolism and the risk of adult brain tumors
  2. De Roos, A. J.; Rothman, N.; Brown, M.; Bell, D. A.; Pittman, G. S.; Shapiro, W. R.; Selker, R. G.; Fine, H. A.; Black, P. M.; Inskip, P. D.
  3. Neuro-Oncology. 2006, Apr; 8(2): 145-155.
  1. 24.   Transcriptomic analysis of an in vitro murine model of ovarian carcinoma: Functional similarity to the human disease and identification of prospective tumoral markers and targets
  2. Urzua, U.; Roby, K. F.; Gangi, L. M.; Cherry, J. M.; Powell, J. I.; Munroe, D. J.
  3. Journal of Cellular Physiology. 2006, MAR; 206(3): 594-602.
  1. 25.   PABA/NO as an anticancer lead: Analogue synthesis, structure revision, solution chemistry, reactivity toward glutathione, and in vitro activity
  2. Saavedra, J. E.; Srinivasan, A.; Buzard, G. S.; Davies, K. M.; Waterhouse, D. J.; Inami, K.; Wilde, T. C.; Citro, M. L.; Cuellar, M.; Deschamps, J. R.; Parrish, D.; Shami, P. J.; Findlay, V. J.; Townsend, D. M.; Tew, K. D.; Singh, S.; Jia, L.; Ji, X. H.; Keefer, L. K.
  3. Journal of Medicinal Chemistry. 2006, FEB 9; 49(3): 1157-1164.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel